Skip to main content
. Author manuscript; available in PMC: 2017 May 1.
Published in final edited form as: Leuk Res. 2016 Mar 10;44:32–39. doi: 10.1016/j.leukres.2016.03.003

Figure 3.

Figure 3

Figure 3

Figure 3

A: Kaplan-Meier plot comparing OS between patients with newly diagnosed MM based on their molecular cytogenetics classification as high risk versus standard risk. B: Kaplan-Meier plot comparing OS between patients with newly diagnosed MM and standard-risk cytogenetics based on the proportion of CD45 expression on the clonal PCs in the bone marrow. C: Kaplan-Meier plot comparing OS between patients with newly diagnosed MM and high-risk cytogenetics based on the proportion of CD45 expression on the clonal PCs in the bone marrow.